Appetite-stimulating hormone is first potential medical treatment for frailty in older women
Older women suffering from clinical frailty stand to benefit from the first potential medical treatment for the condition, according to a study presented today by Penn Medicine researchers at ENDO, The Endocrine Society's 91st Annual Meeting. Ghrelin, a hormone that stimulates appetite, was administered to older women diagnosed with frailty, a common geriatric syndrome characterized by unintentional weight loss, weakness, exhaustion and low levels of anabolic hormones which increases risk of falls, hospitalizations, disability, and death. Those who received ghrelin infusions consumed 51 percent more calories than the placebo group, with an increase in carbohydrate and protein intake, not fat. Their growth hormone levels were also higher throughout the ghrelin infusion.
Read the whole article on Physorg
More from Physorg
Related
- Appetite-stimulating hormone is first potential medical treatment for frailty in older womenFri, 12 Jun 2009, 11:44:39 EDT
- A stronger backbone: DHEA hormone replacement increases bone density in older womenTue, 12 May 2009, 9:52:09 EDT
- Action of ghrelin hormone increases appetite and favors accumulation of abdominal fatWed, 20 May 2009, 9:23:17 EDT
- Risk of frailty in older women dependent on multisystem abnormalitiesThu, 30 Jul 2009, 10:38:14 EDT
- Hormone offers promise as fertility treatmentMon, 16 Mar 2009, 19:36:17 EDT